跳至主要内容
临床试验/NCT00322075
NCT00322075已完成4 期

Comparison of Glycaemic Fluctuations During 3 Days Subcutaneous Continuous Monitoring in Patients With Basal Substitution Human Insulin NPH vs Insuline Glargine

Sanofi2 个研究点 分布在 2 个国家目标入组 35 人开始时间: 2006年4月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Sanofi
入组人数
35
试验地点
2
主要终点
patients´satisfaction

研究概览

简要总结

Comparison of incidence of hypoglycaemic events and glycaemic fluctuations in diabetic patients with basal substitution with NPH insuline versus insuline glargine. Evaluation of HbA1c, FBG (Fasting Blood Glucose), BMI (Body Mass Index), dose of insulin, ratio of basal and prandial insulin, satisfaction with treatment, incidence of adverse events.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Diabetes Mellitus Type 1 and Diabetes Mellitus Type 2 with HbA1c 6% and more with more than 2 confirmed hypoglycaemic events (glycaemia less than 3,3 mmol/l) during last year

排除标准

  • Diabetic ketoacidosis
  • Any other severe disease
  • Pregnancy or fertile female without contraception
  • Alcohol/drug abuse, selected prohibited concomitant medication
  • Nightshift work

结局指标

主要结局

patients´satisfaction

3 days continual glycaemic profile fluctuation

occurrence of adverse events

HbA1c

FBG

BMI

total daily dose of insulin and ratio of doses of basal/prandial insulines

次要结局

未报告次要终点

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验